Variable | Adults | Children |
---|---|---|
Number of participants | 1013 | 360 |
Median age (IQR) at hospital admission, years | 56.8 (47.0–65.8) | 9.5 (2.4–14.8) |
Median time from the hospital discharge to the 1st follow-up point (IQR), days | 215 (196–235) | 255 (223–270) |
Median time from the hospital discharge to the 2nd follow-up point (IQR), days | 383 (376–390) | 367 (351–379) |
Gender (female) | 513/1013 (51%) | 186/360 (52%) |
Severe COVID-19 (requiring non-invasive ventilation or invasive ventilation or ICU) | 27/1013 (3%) | 12/360 (3%) |
Heart diseases | 502/1013 (49%) | 12/360 (3%) |
Chronic cardiac disease | 198/1013 (20%) | N/A |
Hypertension | 458/1013 (45%) | N/A |
History of peripheral or cardiac revascularisation | 51/1013 (5%) | N/A |
Respiratory diseases (not including asthma) | 79/1013 (8%) | 5/360 (1%) |
Allergic respiratory diseases | N/A | 29/360 (8%) |
Asthma (physician diagnosed) | 48/1013 (5%) | 5/360 (1%) |
Allergic rhinitis/hay fever | N/A | 26/360 (7%) |
Kidney disease | 51/1013 (5%) | 6/360 (2%) |
Overweight and obesity (as defined by clinical staff) | 198/1013 (20%) | 10/360 (3%) |
Neurological disorder | 53/1013 (5%) | 11/360 (3%) |
Malignancy | 42/1013 (4%) | 0/360 (0%) |
Haematological conditions | 12/1013 (1%) | 9/360 (3%) |
Diabetes Mellitus | 148/1013 (15%) | 0/360 (0%) |
Rheumatologic disorder | 27/1013 (3%) | 2/360 (1%) |
Tuberculosis | 1/1013 (0%) | 3/360 (1%) |
Malnutrition | 1/1013 (0%) | 10/360 (3%) |
Intestinal (gut) problems | N/A | 25/360 (7%) |